Abstract 5203: Discovery and development of SLD2435, a novel humanized IgG1 bispecific antibody simultaneously targeting human TIGIT and PVRIG for cancer immunotherapyXiaofeng Zhao, Renhong Tang, Xiaoqing Liu et al.|Cancer Research|2022Cited by 0